Skip to main content
Clinical Trials/NCT02982135
NCT02982135
Unknown
Not Applicable

Direct Bypass Versus Indirect Bypass in Treatment of Adults Hemorrhagic Moyamoya Disease:a Prospective Multi-center Cohort Study

liuxingju1 site in 1 country300 target enrollmentJanuary 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Moyamoya Disease
Sponsor
liuxingju
Enrollment
300
Locations
1
Primary Endpoint
rebleeding events
Last Updated
9 years ago

Overview

Brief Summary

The investigators conducted a prospective multi-center study assessing the effect of direct bypass and indrect bypass in treatment of hemorrhagic moyamoya disease.

Registry
clinicaltrials.gov
Start Date
January 2016
End Date
January 2018
Last Updated
9 years ago
Study Type
Interventional
Study Design
Factorial
Sex
All

Investigators

Sponsor
liuxingju
Responsible Party
Sponsor Investigator
Principal Investigator

liuxingju

Principal investigator

Ministry of Science and Technology of the People´s Republic of China

Eligibility Criteria

Inclusion Criteria

  • cerebral digital subtraction contrast angiography (DSA) revealed severe stenosis or occlusion of the distal internal carotid or proximal middle and anterior cerebral arteries with prominent lenticulostriate "moyamoya collaterals"
  • patients had experienced at least one intracranial hemorrhage which was verified by computed tomography (CT) scanning, magnetic resonance imaging MRI), or lumbar puncture.
  • Patients requiring surgery

Exclusion Criteria

  • Patient whose initial onset was marked by ischemia but subsequently suffered from intracranial hemorrhage
  • patients refused to participate in the study

Outcomes

Primary Outcomes

rebleeding events

Time Frame: 5-10 years

Secondary Outcomes

  • postoperative compilications(30 days)
  • ischemic events(5-10 years)

Study Sites (1)

Loading locations...

Similar Trials